Gene · 5699
Papers1,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Thymic and T-cell intrinsic critical roles associated with severe combined immunodeficiency and Omenn syndrome due to a heterozygous variant (G201R) in PSMB10. | J Allergy Clin Immunol | 2025 | 39734035 | PubTator, text mining | PubMed |
Diminished expression of the ubiquitin-proteasome system in early treatment-naïve patients with rheumatoid arthritis and concomitant type 2 diabetes may be linked to IL-1 pathway hyper-activity; results from PEAC cohort. | Arthritis Res Ther | 2024 | 39342401 | PubTator, text mining | PubMed |
| Digital Spatial Profiling identifies distinct patterns of immuno-oncology-related gene expression within oropharyngeal tumours in relation to HPV and p16 status. | Front Oncol | 2024 | 39328208 | PubTator, text mining | PubMed |
| Takin' Out the Trash for Brain Health! | Epilepsy Curr | 2024 | 39309049 | PubTator, text mining | PubMed |
| Disruptions in antigen processing and presentation machinery on sarcoma. | Cancer Immunol Immunother | 2024 | 39249578 | PubTator, text mining | PubMed |
| Primed for Interactions: Investigating the Primed Substrate Channel of the Proteasome for Improved Molecular Engagement. | Molecules | 2024 | 39064934 | PubTator, text mining | PubMed |
| [Establishment of a stable THP-1 cell line expressing PSMB9-eGFP-His protein and detection of immunoproteasome activity]. | Sheng Wu Gong Cheng Xue Bao | 2024 | 39044591 | PubTator, text mining | PubMed |
| For Whom Does Education Convey Health Benefits? A Two-Generation and Life Course Approach. | J Health Soc Behav | 2024 | 38832718 | PubTator, text mining | PubMed |
| Evaluating the Role of Neddylation Modifications in Kidney Renal Clear Cell Carcinoma: An Integrated Approach Using Bioinformatics, MLN4924 Dosing Experiments, and RNA Sequencing. | Pharmaceuticals (Basel) | 2024 | 38794205 | PubTator, text mining | PubMed |
| Corrigendum to "The Immunoproteasome Subunit LMP10 Mediates Angiotensin II-induced Retinopathy in Mice" [Redox Biol. 16 (2018) 129-138]. | Redox Biol | 2024 | 38729784 | PubTator, text mining | PubMed |
| Inhibition of Immunoproteasome Attenuates NLRP3 Inflammasome Response by Regulating E3 Ubiquitin Ligase TRIM31. | Cells | 2024 | 38667290 | PubTator, text mining | PubMed |
| Corrigendum to "The immunoproteasome subunit LMP10 mediates angiotensin II-induced retinopathy in mice" [Redox Biol. 16 (2018) 129-138]. | Redox Biol | 2024 | 38653649 | PubTator, text mining | PubMed |
| Expanding the PRAAS spectrum: De novo mutations of immunoproteasome subunit β-type 10 in six infants with SCID-Omenn syndrome. | Am J Hum Genet | 2024 | 38503300 | Swiss-Prot, curated | PubMed |
| Proteasome composition in immune cells implies special immune‐cell‐specific immunoproteasome function. | Eur J Immunol | 2024 | 38458995 | PubTator, text mining | PubMed |
| Protein Quality Control Systems and ER Stress as Key Players in SARS-CoV-2-Induced Neurodegeneration. | Cells | 2024 | 38247815 | PubTator, text mining | PubMed |
| ATR inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines. | Oncotarget | 2024 | 38227740 | PubTator, text mining | PubMed |
| Antiviral effects of micafungin against pteropine orthoreovirus, an emerging zoonotic virus carried by bats. | Virus Res | 2024 | 37858730 | PubTator, text mining | PubMed |
| Assessing functional impulsivity using functional near-infrared spectroscopy. | Front Neuroergon | 2023 | 38234501 | PubTator, text mining | PubMed |
| Predicting T Cell-Inflamed Gene Expression Profile in Hepatocellular Carcinoma Based on Dynamic Contrast-Enhanced Ultrasound Radiomics. | J Hepatocell Carcinoma | 2023 | 38143911 | PubTator, text mining | PubMed |
| Proteomic Analysis of Human iPSC-Derived Neural Stem Cells and Motor Neurons Identifies Proteasome Structural Alterations. | Cells | 2023 | 38132120 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5699/papers?page=3